A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma

Phase I study of temozolomide in combination with thiotepa and carboplatin with autologous hematopoietic cell rescue in patients with malignant brain tumors with minimal residual disease

(2016) G Egan et al.   BONE MARROW TRANSPLANTATION

Survival After Relapse of Medulloblastoma

(2016) Carl Koschmann et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy

(2015) Kim Kramer et al.   JOURNAL OF NEURO-ONCOLOGY

GD2-Targeted Immunotherapy and Radioimmunotherapy

(2014) Konstantin Dobrenkov et al.   SEMINARS IN ONCOLOGY

Complement Activation and Intraventricular Rituximab Distribution in Recurrent Central Nervous System Lymphoma

(2013) C. Kadoch et al.   CLINICAL CANCER RESEARCH

A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

(2013) Nathan J. Robison et al.   PEDIATRIC BLOOD & CANCER

Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission

(2012) Nai-Kong V. Cheung et al.   JOURNAL OF CLINICAL ONCOLOGY

Reirradiation for recurrent medulloblastoma

(2011) Richard L. Bakst et al.   CANCER

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma

(2011) I. J. Dunkel et al.   NEURO-ONCOLOGY

Radioimmunotargeting of malignant glioma by monoclonal antibody D2C7 reactive against both wild-type and variant III mutant epidermal growth factor receptors

(2011) Michael R. Zalutsky et al.   NUCLEAR MEDICINE AND BIOLOGY

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

(2010) Alice L. Yu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma

(2009) Kim Kramer et al.   JOURNAL OF NEURO-ONCOLOGY

High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors

(2008) Chie-Schin Shih et al.   CANCER

Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma

(2008) Sridharan Gururangan et al.   NEURO-ONCOLOGY

A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost

(2008) David A. Reardon et al.   NEURO-ONCOLOGY